The corporate vision is "Innovations for a Better Life". With the focused aim on liver diseases and cancers of Asian significance, MBC exploits this expertise to develop new drugs/technologies in these two principle areas, in addition to nucleic acid testing of HLA, HBV/HCV/HIV and other pathogens. Bridging  biomedical R&D niches with international collaborations, MBC strives to translate basic research into FDA approved applications through its state-of-the-art molecular and clinical competence. On the mission of a better life for society and mankind, MBC vows to become a leader in the fight against liver diseases and cancer in Asia, one innovation at a time.